SCHEMBL13488138

SCHEMBL13488138

CC1(C)c2ccccc2-c2ccc(-c3ccc4c(-c5ccc6nc(-c7ccccc7)c(-c7ccccc7)nc6c5)c5ccccc5c(-c5ccc6c(c5)C(C)(C)c5ccccc5-6)c4c3)cc21

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 9/20 0.41
KDM4E B2RXH2 8/20 0.41
L3MBTL1 Q9Y468 5/20 0.41
KMT2A Q03164 3/20 0.38
ATM Q13315 1/20 0.38
TLR9 Q9NR96 1/20 0.38
TDP1 Q9NUW8 3/20 0.37
PIK3R1 P27986 1/20 0.36
PIK3CA P42336 1/20 0.36
GAA P10253 3/20 0.36
HPGD P15428 3/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
NPC1 O15118 1/20 0.36
RAB9A P51151 1/20 0.36
LMNA P02545 7/20 0.36
NPSR1 Q6W5P4 1/20 0.35
HTT P42858 1/20 0.34
RXFP1 Q9HBX9 1/20 0.34
THRB P10828 1/20 0.34
PDK2 Q15119 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13487906 0.99 KDM4E (0.40) ALDH1A1KDM4EL3MBTL1KMT2AATM
SCHEMBL13487814 0.97 ALDH1A1 (0.39) ALDH1A1KDM4EL3MBTL1KMT2AATM
SCHEMBL13488063 0.95 KDM4E (0.37) ALDH1A1KDM4EL3MBTL1KMT2AATM
SCHEMBL13488137 0.94 TDP1 (0.39) ALDH1A1KDM4EL3MBTL1KMT2AATM
SCHEMBL13487375 0.94 ALDH1A1 (0.36) ALDH1A1KDM4EL3MBTL1KMT2AATM
SCHEMBL13487908 0.93 TDP1 (0.38) ALDH1A1KDM4EL3MBTL1KMT2AATM
SCHEMBL13487986 0.93 ALDH1A1 (0.37) ALDH1A1KDM4EL3MBTL1KMT2AATM
SCHEMBL13487841 0.92 ALDH1A1 (0.50) ALDH1A1KDM4EL3MBTL1KMT2AATM
SCHEMBL13487523 0.92 ALDH1A1 (0.40) ALDH1A1KDM4EL3MBTL1KMT2AATM
SCHEMBL13487750 0.91 TDP1 (0.36) ALDH1A1KDM4EL3MBTL1KMT2AATM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100045170-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2010-02-25 US disclosed
US-20100045170-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2010-02-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100045170-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same OCIAD1, OCIAD2, ORMDL3 ALDH1A1 101/4885KDM4E 3671/4885L3MBTL1 1193/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.